Clinical Trials Browser

Interventional × avelumab × Other solid neoplasm × Clear all

NCT06302426 2026-01-16

Trial of INI-4001 in Patients With Advanced Solid Tumours

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT03707808 2025-01-20

myDAvIpNi

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT02994953 2024-09-20

COMBO

Phase 1 Terminated

52 enrolled 34 charts

Other solid neoplasm

Advanced Solid Tumors

NCT03523390 2024-02-23

Phase I/Ib Multiple Ascending Dose Study in China

Phase 1 Completed

24 enrolled 24 charts

Other solid neoplasm

Metastatic Solid Tumors

NCT03399552 2023-10-23

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Phase 1/2 Completed

15 enrolled 8 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Phase 2 Unknown

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT03491345 2022-08-09

K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor

Phase 2 Unknown

Other solid neoplasm

PD-L1 Positive Mutation Tumor

NCT02923466 2022-04-27

Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumour